Clinical Trial: Achievement of Goal Resting Heart Rate on B-blockers in Patients With Stable Angina and Hypertension
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Observational Non-interventional Study - Epidemiological Survey "AchievemenT of Goal Resting HEart Rate on Beta-blockers in Patients With Stable angiNA and Hypertensi
Brief Summary: This is a multicenter survey of Russian data on target heart rate achievement in patients with stable angina and arterial hypertension who are currently treated with beta-blockers for at least 2 months and with no dose change for a minimum of 4 weeks
Detailed Summary:
Sponsor: AstraZeneca
Current Primary Outcome: Establish the proportion of patients with stable angina and hypertension on beta-blockers reaching the resting HR goals according to ACC/AHA/ACP-ASIM* Guidelines [ Time Frame: 1 visit within 5 month ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Establish the mean dose of each beta-blocker in patients who achieved and not achieved resting HR goals [ Time Frame: 1 visit within 5 month ]
- Compare quality of life in patients who achieved and non achieved resting HR goals [ Time Frame: 1 visit within 5 month ]
- To estimate the correlation between achievement of resting HR goals according to ACC/AHA/ACP-ASIM Guidelines for the management of patients [ Time Frame: 1 visits within 5 month ]
Original Secondary Outcome: Same as current
Information By: AstraZeneca
Dates:
Date Received: March 22, 2011
Date Started: April 2011
Date Completion:
Last Updated: May 31, 2012
Last Verified: May 2012